Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG

Hypertriglyceridemia (HTG) is associated with insulin resistance, increased cholesteryl ester transfer (CET), and low HDL cholesterol. Phospholipid transfer protein (PLTP) may be involved in these relationships. Associations between CET, lipids, insulin resistance, CETP and PLTP activities, and PLTP...

Full description

Bibliographic Details
Main Authors: Iris J.A.M. Jonkers, Augustinus H.M. Smelt, Hiroaki Hattori, Leo M. Scheek, Teus van Gent, Frits H.A.F. de Man, Arnoud van der Laarse, Arie van Tol
Format: Article
Language:English
Published: Elsevier 2003-08-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520337548
_version_ 1818671433400713216
author Iris J.A.M. Jonkers
Augustinus H.M. Smelt
Hiroaki Hattori
Leo M. Scheek
Teus van Gent
Frits H.A.F. de Man
Arnoud van der Laarse
Arie van Tol
author_facet Iris J.A.M. Jonkers
Augustinus H.M. Smelt
Hiroaki Hattori
Leo M. Scheek
Teus van Gent
Frits H.A.F. de Man
Arnoud van der Laarse
Arie van Tol
author_sort Iris J.A.M. Jonkers
collection DOAJ
description Hypertriglyceridemia (HTG) is associated with insulin resistance, increased cholesteryl ester transfer (CET), and low HDL cholesterol. Phospholipid transfer protein (PLTP) may be involved in these relationships. Associations between CET, lipids, insulin resistance, CETP and PLTP activities, and PLTP mass were investigated in 18 HTG patients and 20 controls. Effects of 6 weeks of bezafibrate treatment were studied in HTG patients. HTG patients had higher serum triglycerides, insulin resistance, free fatty acid (FFA), and CET, lower levels of HDL cholesterol (−44%) and PLTP mass (−54%), and higher CETP (+20%) and PLTP activity (+48%) than controls. Bezafibrate reduced triglycerides, CET (−37%), insulin resistance (−53%), FFA (−48%), CETP activity (−12%), PLTP activity (−8%), and increased HDL cholesterol (+27%), whereas PLTP mass remained unchanged. Regression analysis showed a positive contribution of PLTP mass (P = 0.001) but not of PLTP activity to HDL cholesterol, whereas insulin resistance positively contributed to PLTP activity (P < 0.01). Bezafibrate-induced change in CET and HDL cholesterol correlated with changes in CETP activity and FFAs, but not with change in PLTP activity. Bezafibrate-induced change in PLTP activity correlated with change in FFAs (r = 0.455, P = 0.058). We propose that elevated PLTP activity in HTG is related to insulin resistance and not to increased PLTP mass.Bezafibrate-induced diminished insulin resistance is associated with a reduction of CET and PLTP activity.
first_indexed 2024-12-17T07:23:55Z
format Article
id doaj.art-ac3d8c0f5eed4142840cb5cba995a537
institution Directory Open Access Journal
issn 0022-2275
language English
last_indexed 2024-12-17T07:23:55Z
publishDate 2003-08-01
publisher Elsevier
record_format Article
series Journal of Lipid Research
spelling doaj.art-ac3d8c0f5eed4142840cb5cba995a5372022-12-21T21:58:41ZengElsevierJournal of Lipid Research0022-22752003-08-0144814621469Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTGIris J.A.M. Jonkers0Augustinus H.M. Smelt1Hiroaki Hattori2Leo M. Scheek3Teus van Gent4Frits H.A.F. de Man5Arnoud van der Laarse6Arie van Tol7Department of General Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands; Research Division, R&D Center, BML, Inc., 1361-1 Matoba, Kawagoe, Saitama, Japan; Department of Biochemistry, Erasmus Medical Center, Rotterdam, The NetherlandsDepartment of General Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands; Research Division, R&D Center, BML, Inc., 1361-1 Matoba, Kawagoe, Saitama, Japan; Department of Biochemistry, Erasmus Medical Center, Rotterdam, The NetherlandsDepartment of General Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands; Research Division, R&D Center, BML, Inc., 1361-1 Matoba, Kawagoe, Saitama, Japan; Department of Biochemistry, Erasmus Medical Center, Rotterdam, The NetherlandsDepartment of General Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands; Research Division, R&D Center, BML, Inc., 1361-1 Matoba, Kawagoe, Saitama, Japan; Department of Biochemistry, Erasmus Medical Center, Rotterdam, The NetherlandsDepartment of General Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands; Research Division, R&D Center, BML, Inc., 1361-1 Matoba, Kawagoe, Saitama, Japan; Department of Biochemistry, Erasmus Medical Center, Rotterdam, The NetherlandsDepartment of General Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands; Research Division, R&D Center, BML, Inc., 1361-1 Matoba, Kawagoe, Saitama, Japan; Department of Biochemistry, Erasmus Medical Center, Rotterdam, The NetherlandsDepartment of General Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands; Research Division, R&D Center, BML, Inc., 1361-1 Matoba, Kawagoe, Saitama, Japan; Department of Biochemistry, Erasmus Medical Center, Rotterdam, The NetherlandsDepartment of General Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands; Research Division, R&D Center, BML, Inc., 1361-1 Matoba, Kawagoe, Saitama, Japan; Department of Biochemistry, Erasmus Medical Center, Rotterdam, The NetherlandsHypertriglyceridemia (HTG) is associated with insulin resistance, increased cholesteryl ester transfer (CET), and low HDL cholesterol. Phospholipid transfer protein (PLTP) may be involved in these relationships. Associations between CET, lipids, insulin resistance, CETP and PLTP activities, and PLTP mass were investigated in 18 HTG patients and 20 controls. Effects of 6 weeks of bezafibrate treatment were studied in HTG patients. HTG patients had higher serum triglycerides, insulin resistance, free fatty acid (FFA), and CET, lower levels of HDL cholesterol (−44%) and PLTP mass (−54%), and higher CETP (+20%) and PLTP activity (+48%) than controls. Bezafibrate reduced triglycerides, CET (−37%), insulin resistance (−53%), FFA (−48%), CETP activity (−12%), PLTP activity (−8%), and increased HDL cholesterol (+27%), whereas PLTP mass remained unchanged. Regression analysis showed a positive contribution of PLTP mass (P = 0.001) but not of PLTP activity to HDL cholesterol, whereas insulin resistance positively contributed to PLTP activity (P < 0.01). Bezafibrate-induced change in CET and HDL cholesterol correlated with changes in CETP activity and FFAs, but not with change in PLTP activity. Bezafibrate-induced change in PLTP activity correlated with change in FFAs (r = 0.455, P = 0.058). We propose that elevated PLTP activity in HTG is related to insulin resistance and not to increased PLTP mass.Bezafibrate-induced diminished insulin resistance is associated with a reduction of CET and PLTP activity.http://www.sciencedirect.com/science/article/pii/S0022227520337548phospholipid transfer proteincholesteryl ester transfertriglycerideshypertriglyceridemia
spellingShingle Iris J.A.M. Jonkers
Augustinus H.M. Smelt
Hiroaki Hattori
Leo M. Scheek
Teus van Gent
Frits H.A.F. de Man
Arnoud van der Laarse
Arie van Tol
Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG
Journal of Lipid Research
phospholipid transfer protein
cholesteryl ester transfer
triglycerides
hypertriglyceridemia
title Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG
title_full Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG
title_fullStr Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG
title_full_unstemmed Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG
title_short Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG
title_sort decreased pltp mass but elevated pltp activity linked to insulin resistance in htg
topic phospholipid transfer protein
cholesteryl ester transfer
triglycerides
hypertriglyceridemia
url http://www.sciencedirect.com/science/article/pii/S0022227520337548
work_keys_str_mv AT irisjamjonkers decreasedpltpmassbutelevatedpltpactivitylinkedtoinsulinresistanceinhtg
AT augustinushmsmelt decreasedpltpmassbutelevatedpltpactivitylinkedtoinsulinresistanceinhtg
AT hiroakihattori decreasedpltpmassbutelevatedpltpactivitylinkedtoinsulinresistanceinhtg
AT leomscheek decreasedpltpmassbutelevatedpltpactivitylinkedtoinsulinresistanceinhtg
AT teusvangent decreasedpltpmassbutelevatedpltpactivitylinkedtoinsulinresistanceinhtg
AT fritshafdeman decreasedpltpmassbutelevatedpltpactivitylinkedtoinsulinresistanceinhtg
AT arnoudvanderlaarse decreasedpltpmassbutelevatedpltpactivitylinkedtoinsulinresistanceinhtg
AT arievantol decreasedpltpmassbutelevatedpltpactivitylinkedtoinsulinresistanceinhtg